87 results
Page 3 of 5
424B3
ulzlg9fjwldy86
28 Jun 21
Prospectus supplement
9:18am
424B3
4poul80ugu
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.1
lmjn0g
28 Jun 21
Current report (foreign)
9:16am
F-4
k0wno77e
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
ybis1f7w4b4g
3 Jun 21
Prospectus supplement
6:06am
424B3
apca3b1 7p4
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
wajiq
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
rsd3438z eam
2 Jun 21
Prospectus supplement
10:10am
424B3
095 gmxkvqoeh
2 Jun 21
Prospectus supplement
10:09am
424B3
qv82 sclw
2 Jun 21
Prospectus supplement
10:08am
425
dj6l0xqah
5 May 21
Business combination disclosure
5:27pm
6-K
EX-99.1
3qbu 1dyck3y
5 May 21
Agreement and Plan of Merger
5:19pm
20-F
7hd8img
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.3
2b3uumc rq9hdyz2zgt
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
19vhfdezqoj
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
j1trg4gxo 7cgd03e
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
xnq7 e7z0dqg
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
su3ta qkr65506
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
hd9yufysh7z0
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
hgxxevbo 73v5ngqp
8 Jan 21
Registration statement (foreign)
4:58pm